Table 3: Self-reported indications for flexible sigmoidoscopy or colonoscopy within preceding 10 years
Jurisdiction; % of respondents who had test
VariableNLPEINSNBQCONMBSKABBCTerritories*Canada
Age 5074 yr
Family history30.919.617.823.318.515.413.118.518.520.024.917.5
Routine screening23.823.636.233.535.055.636.136.743.536.341.645.0
Age2.29.84.98.86.315.68.67.98.65.89.510.7
Follow-up of problem45.956.446.943.135.628.538.337.730.738.728.933.1
Follow-up of CRC treatment3.30.13.12.92.91.31.63.31.61.82.61.9
Age 4049 yr
Family history48.313.418.444.017.028.432.332.823.928.630.625.8
Routine screening17.10.014.511.314.027.514.24.510.212.619.518.4
Age0.00.00.01.25.23.03.70.90.70.61..22.8
Follow-up of problem35.686.672.547.356.648.250.962.847.464.150.052.6
Follow-up of CRC treatment1.20.00.00.40.100000.50.80.2
Age ≥ 74 yr
Family history11.112.512.115.19.57.710.416.28.610.412.19.3
Routine screening21.230.730.834.345.357.738.933.550.043.853.449.2
Age0.02.11.63.75.511.81.01.811.83.40.07.9
Follow-up of problem65.856.249.250.834.833.544.951.429.738.728.936.6
Follow-up of CRC treatment4.90.08.34.05.73.73.13.72.73.45.64.2

Note: AB = Alberta, BC = British Columbia, CRC = colorectal cancer, MB = Manitoba, NB = New Brunswick, NL = Newfoundland and Labrador, NS = Nova Scotia, ON = Ontario, PEI = Prince Edward Island, QC = Quebec, SK = Saskatchewan.
*Northwest Territories, Yukon and Nunavut.